121 related articles for article (PubMed ID: 10493000)
1. [Use of prognostic factors of disease progression in the treatment of patients with stage I nonseminomatous testicular tumors].
Ondrus D
Bratisl Lek Listy; 1999 Jan; 100(1):61-5. PubMed ID: 10493000
[TBL] [Abstract][Full Text] [Related]
2. Nonseminomatous germ cell testicular tumors clinical stage I: differentiated therapeutic approach in comparison with therapeutic approach using surveillance strategy only.
Ondrus D; Ondrusova M; Hornak M; Matoska J
Neoplasma; 2007; 54(5):437-42. PubMed ID: 17688374
[TBL] [Abstract][Full Text] [Related]
3. Prognostic factors in clinical stage I nonseminomatous germ cell testicular tumors: rationale for different risk-adapted treatment.
Ondrus D; Matoska J; Belan V; Kausitz J; Goncalves F; Hornák M
Eur Urol; 1998; 33(6):562-6. PubMed ID: 9743698
[TBL] [Abstract][Full Text] [Related]
4. The value of prognostic factors in the management of stage I nonseminomatous germ cell testicular tumors (NSGCTT).
Ondrus D; Goncalves F; Kausitz J; Mat'oska J; Belan V
Neoplasma; 1996; 43(3):195-7. PubMed ID: 8841507
[TBL] [Abstract][Full Text] [Related]
5. Orchiectomy alone for clinical stage I nonseminomatous germ cell tumors of the testis (NSGCTT): a minimum follow-up period of 5 years.
Ondrus D; Hornak M
Tumori; 1994 Oct; 80(5):362-4. PubMed ID: 7839467
[TBL] [Abstract][Full Text] [Related]
6. [Efficacy of modified retroperitoneal lymph node dissection for testicular nonseminomatous germ cell tumors].
Liu ZW; Zhou FJ; Han H; Qin ZK; Yu SL; Li YH; Ye YL; Teng XY
Ai Zheng; 2008 Dec; 27(12):1302-6. PubMed ID: 19079998
[TBL] [Abstract][Full Text] [Related]
7. Minimizing treatment without compromising cure with primary surveillance for clinical stage I embryonal predominant nonseminomatous testicular cancer: a population based analysis from British Columbia.
Al-Tourah AJ; Murray N; Coppin C; Kollmannsberger C; Man A; Chi KN
J Urol; 2005 Dec; 174(6):2209-13, discussion 2213. PubMed ID: 16280765
[TBL] [Abstract][Full Text] [Related]
8. Clinical stage I nonseminomatous germ cell tumors of the testis in childhood and adolescence: an analysis of 31 cases.
Terenziani M; Piva L; Spreafico F; Salvioni R; Massimino M; Luksch R; Cefalo G; Casanova M; Ferrari A; Polastri D; Mazza E; Bellani FF; Nicolai N
J Pediatr Hematol Oncol; 2002; 24(6):454-8. PubMed ID: 12218592
[TBL] [Abstract][Full Text] [Related]
9. Controversies in the management of clinical stage I nonseminomatous germ cell testicular cancer.
Ondrus D; Kajo K; Stastna V; Ondrusova M
Klin Onkol; 2015; 28(2):112-5. PubMed ID: 25882021
[TBL] [Abstract][Full Text] [Related]
10. [Delayed orchiectomy and surgery of metastases after primary chemotherapy in the treatment of advanced testicular tumors].
Ondrus D; Hornák M; Schnorrer M; Mat'oska J
Rozhl Chir; 2001 Nov; 80(11):612-4. PubMed ID: 11794064
[TBL] [Abstract][Full Text] [Related]
11. [Histopathologic risk factors in patients with non-seminomatous germ tumors of the testis in clinical stage 1. Retrospective study of 75 patients].
Porcaro AB; Zecchini Antoniolli S; Novella G; Martignoni G; Bassetto MA; Poli A; Schiavone D; Tallarigo C; D'Amico A; Ficarra V; Curti P
Arch Ital Urol Androl; 2001 Dec; 73(4):177-80. PubMed ID: 11822063
[TBL] [Abstract][Full Text] [Related]
12. [Efficacy analysis of three therapeutic modes on clinical stage Ia nonseminomatous germ cell testicular tumors].
Dong P; Liu ZW; Li XD; Wu S; Li YH; Yao K; Qin ZK; Han H; Zhou FJ
Zhonghua Wai Ke Za Zhi; 2013 Mar; 51(3):256-60. PubMed ID: 23859330
[TBL] [Abstract][Full Text] [Related]
13. Laparoscopic retroperitoneal lymph node dissection combined with adjuvant chemotherapy for pathological stage II disease in nonseminomatous germ cell tumours: a 15-year experience.
Cresswell J; Scheitlin W; Gozen A; Lenz E; Teber D; Rassweiler J
BJU Int; 2008 Sep; 102(7):844-8. PubMed ID: 18537954
[TBL] [Abstract][Full Text] [Related]
14. Teratoma in primary testis tumor reduces complete response rates in the retroperitoneum after primary chemotherapy. The case for primary retroperitoneal lymph node dissection of stage IIb germ cell tumors with teratomatous elements.
Rabbani F; Gleave ME; Coppin CM; Murray N; Sullivan LD
Cancer; 1996 Aug; 78(3):480-6. PubMed ID: 8697394
[TBL] [Abstract][Full Text] [Related]
15. Germ cell tumor associated primitive neuroectodermal tumors.
Ganjoo KN; Foster RS; Michael H; Donohue JP; Einhorn LH
J Urol; 2001 May; 165(5):1514-6. PubMed ID: 11342908
[TBL] [Abstract][Full Text] [Related]
16. Long-term results following adjuvant chemotherapy in patients with clinical stage I testicular nonseminomatous malignant germ cell tumors with high risk factors.
Böhlen D; Borner M; Sonntag RW; Fey MF; Studer UE
J Urol; 1999 Apr; 161(4):1148-52. PubMed ID: 10081858
[TBL] [Abstract][Full Text] [Related]
17. Retroperitoneal lymph node dissection for nonseminomatous germ cell testicular cancer: impact of patient selection factors on outcome.
Stephenson AJ; Bosl GJ; Motzer RJ; Kattan MW; Stasi J; Bajorin DF; Sheinfeld J
J Clin Oncol; 2005 Apr; 23(12):2781-8. PubMed ID: 15837993
[TBL] [Abstract][Full Text] [Related]
18. Outcomes of surveillance protocol of clinical stage I nonseminomatous germ cell tumors-is shift to risk adapted policy justified?
Divrik RT; Akdoğan B; Ozen H; Zorlu F
J Urol; 2006 Oct; 176(4 Pt 1):1424-29; discussion 1429-30. PubMed ID: 16952649
[TBL] [Abstract][Full Text] [Related]
19. Surveillance can be the standard of care for stage I nonseminomatous testicular tumors and even high risk patients.
Roeleveld TA; Horenblas S; Meinhardt W; van de Vijver M; Kooi M; ten Bokkel Huinink WW
J Urol; 2001 Dec; 166(6):2166-70. PubMed ID: 11696728
[TBL] [Abstract][Full Text] [Related]
20. Risk-adapted management for patients with clinical stage I non-seminomatous germ cell tumour of the testis.
Guney S; Guney N; Sonmez NC; Ergenekon E
Med Oncol; 2009; 26(2):136-42. PubMed ID: 18821067
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
